CNBC Dubai: Prof. Polosa speaker on Harm Reduction
Among the distinguished speakers, also the expected speech by prof. Riccardo Polosa, founder of CoEHAR.
Riccardo Polosa at the National Congress of the Italian Society of Internal Medicine
Harm Reduction strategies were the subject of a speech by prof. Polosa during the National Congress of the Italian Society of Internal Medicine. Focus of this year edition, the management of…
Replica Project at the Scientific Summit on Tobacco Harm Reduction
The 5th Scientific Summit on Tobacco Harm Reduction: Novel products, Research & Policy, is organised by SCOHRE, the International Association on Smoking Control & Harm Reduction, and will be held on…
Polosa and Goniewicz the world’s most influential e-cigarette researchers, a new bibliometrics analysis concludes
The mapping of Global Research on electronic cigarettes showed that prof. Riccardo Polosa (CoEHAR Center of Excellence for the Acceleration of HArm Reduction, University of Catania) and prof. Maciej L. Goniewicz (Roswell Park Comprehensive Cancer Center, USA) are the most influential authors and the most important researchers in the e-cigarettes research field.
Evidence for Clinicians: E-Cigarettes a Better Chance at Health
The In Silico Science research team conducted a series of robust and exhaustive systematic reviews to bring forward the best available evidence on the health effects of e-cigarettes on human health developing data for clinicians
US: end of teen nicotine vaping epidemic and eradication of tobacco smoking
The use of e-cigarette among teenagers in the United States is considered a significant public health problem. A close look at federal data now show that the number of young e-cigarette users has markedly declined to below epidemic levels since its peak in 2019.
First study in the world to evaluate efficacy and safety of the antismoking drug varenicline for smokers with Diabetes
A recent randomized controlled trial of varenicline (Chantix) combined with psychological support has significantly increased the chance of quitting smoking for 300 smokers with type 2 diabetes mellitus
The first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature
Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.
Smoking cessation policies in Brazil and UK: the law behind ecig
In a recently published paper, “Health protection, public policies for smoking cessation and regulation of electronic cigarettes in Brazil and the UK: a study of comparative public law”, by Costanza Nicolosi, expert in the economics of legal regulation and Ph.D. in law, the author analyzes the legal approach taken by two countries, UK and Brazil, in e-cigarettes’ regulation, marketing, and production
CoEHAR round table: evidence for tobacco harm reversal from combustion free products
On Tuesday 12 and Wednesday 13 April, a seminar on Harm Reduction has been organized by CoEHAR at the Biologic Tower of the University of Catania, with the participation of…
